Home » Newsletters » BioWorld Science

BioWorld Science

May 22, 2006

View Archived Issues

COL-3 shows promise in AIDS-related Kaposi's sarcoma

Matuzumab/gemcitabine combination feasible in pancreatic cancer

Elemene inhibits laryngeal cancer cell growth

Activity of BXL-628 indicative of efficacy in overactive bladder

DDP-225 improves bladder irritation and capacity in animal models

IP-751 demonstrates efficacy against bladder irritation in vivo

Vertex begins clinical trial for potential cystic fibrosis treatment

Arginox continues to enroll TRIUMPH trial for cardiogenic shock

R-343 selected for advanced preclinical development as allergic asthma treatment

Neotropix's oncolytic virus candidate SVV-001 cleared for clinical trials

Biosite voluntarily withdraws PMA for Triage Stroke Panel

Amarin acquires rights to novel formulation of apomorphine

Agreement for preclinical testing of synDNA H5N1 avian flu vaccine candidates

Terumo and Yakult Honsha to codevelopment liposomal irinotecan

deCODE advances DG-031 to phase III for heart attack prevention

New spinout Cabrellis Pharmaceuticals begins operations

Collaboration to develop treatment for spinal muscular atrophy

Midway receives funding for gastrointestinal therapy development program

Peptech acquisition strengthens company's product pipeline

Health Canada approves Aromasin for adjuvant sequential therapy in early-stage breast cancer

Orion and Abbott consider continued development of levosimendan

Bristol-Myers Squibb discontinues muraglitazar development

Promising phase II results reported for leuprolide in Alzheimer's disease treatment

Therapeutic agents for respiratory disorders described in recent patents

Recent patents disclose new therapeutics for psychological disorders

Remicade approved as first biologic treatment for active pediatric Crohn's disease

Agents for arthritis and other inflammatory disorders reported

Prostaglandin D2 receptor 1 antagonist effective in reducing nicotinic acid-induced vasodilation

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...